Blinatumomab for Acute Lymphoblastic Leukemia.

Kantarjian, Hagop

Blinatumomab for Acute Lymphoblastic Leukemia. [electronic resource] - The New England journal of medicine 06 2017 - e49 p. digital

Publication Type: Letter; Comment

1533-4406

10.1056/NEJMc1704012 doi


Antibodies, Bispecific--therapeutic use
Antineoplastic Agents--therapeutic use
Humans
Precursor Cell Lymphoblastic Leukemia-Lymphoma--drug therapy